Patents by Inventor Cindy A. Jacobs

Cindy A. Jacobs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING CYTISINE IN THE TREATMENT AND/OR PREVENTION OF ADDICTION IN SUBJECTS IN NEED THEREOF
    Publication number: 20210330652
    Abstract: Methods of treatment of addiction and/or dependence, methods of promoting cessation of various addictions, such as smoking and/or vaping, and methods of promoting a reduction in various addictions, such as smoking and/or vaping, uses of cytisine as an addiction cessation treatment, and dosage regimens for the foregoing are provided.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 28, 2021
    Inventors: Cindy A. Jacobs, Daniel F. Cain, Anthony Clarke
  • Compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof
    Patent number: 11083715
    Abstract: Methods of treatment of addiction and/or dependence, methods of promoting cessation of various addictions, such as smoking and/or vaping, and methods of promoting a reduction in various addictions, such as smoking and/or vaping, uses of cytisine as an addiction cessation treatment, and dosage regimens for the foregoing are provided.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: August 10, 2021
    Assignee: Achieve Life Sciences, Inc.
    Inventors: Cindy A. Jacobs, Daniel F. Cain, Anthony Clarke
  • Compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof
    Patent number: 11083716
    Abstract: Methods of treatment of addiction and/or dependence, methods of promoting cessation of various addictions, such as smoking and/or vaping, and methods of promoting a reduction in various addictions, such as smoking and/or vaping, uses of cytisine as an addiction cessation treatment, and dosage regimens for the foregoing are provided.
    Type: Grant
    Filed: November 23, 2020
    Date of Patent: August 10, 2021
    Assignee: Achieve Life Sciences, Inc.
    Inventors: Cindy A. Jacobs, Daniel F. Cain, Anthony Clarke
  • COMPOSITIONS COMPRISING CYTISINE IN THE TREATMENT AND/OR PREVENTION OF ADDICTION IN SUBJECTS IN NEED THEREOF
    Publication number: 20210077475
    Abstract: Methods of treatment of addiction and/or dependence, methods of promoting cessation of various addictions, such as smoking and/or vaping, and methods of promoting a reduction in various addictions, such as smoking and/or vaping, uses of cytisine as an addiction cessation treatment, and dosage regimens for the foregoing are provided.
    Type: Application
    Filed: November 23, 2020
    Publication date: March 18, 2021
    Inventors: Cindy A. Jacobs, Daniel F. Cain, Anthony Clarke
  • COMPOSITIONS COMPRISING CYTISINE IN THE TREATMENT AND/OR PREVENTION OF ADDICTION IN SUBJECTS IN NEED THEREOF
    Publication number: 20210077473
    Abstract: Methods of treatment of addiction and/or dependence, methods of promoting cessation of various addictions, such as smoking and/or vaping, and methods of promoting a reduction in various addictions, such as smoking and/or vaping, uses of cytisine as an addiction cessation treatment, and dosage regimens for the foregoing are provided.
    Type: Application
    Filed: August 14, 2020
    Publication date: March 18, 2021
    Inventors: Cindy A. Jacobs, Daniel F. Cain, Anthony Clarke
  • Method for Selecting Patient Subpopulation for Custirsen Treatment
    Publication number: 20170083675
    Abstract: A method of determining if a cancer patient is susceptible to survival prolongation if treatment is augmented with a clusterin-inhibiting pharmaceutical is provided. The method involves measurement of various patient data and a systematic approach to the analysis. A computer-aided system is also provided.
    Type: Application
    Filed: December 30, 2015
    Publication date: March 23, 2017
    Applicant: OncoGenex Technologies Inc.
    Inventors: Cindy Jacobs, Brent A. Blumenstein
  • Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor
    Patent number: 5605690
    Abstract: A method for treating TNF-dependent inflammatory diseases in a mammal by administering a TNF antagonist, such as soluble TNFR.
    Type: Grant
    Filed: February 8, 1995
    Date of Patent: February 25, 1997
    Assignee: Immunex Corporation
    Inventors: Cindy A. Jacobs, Craig A. Smith
  • Method for promoting wound healing using IL-1
    Patent number: 5202118
    Abstract: Wound healing compositions comprising IL-1.alpha. and IL-1.beta. proteins in a physiologically acceptable hydrophilic vehicle are used to promote wound healing.
    Type: Grant
    Filed: May 6, 1991
    Date of Patent: April 13, 1993
    Assignee: Immunex Corporation
    Inventors: Steven Gillis, Cindy A. Jacobs
  • Anti-arthritic use of interleukin-1 proteins
    Patent number: 4816436
    Abstract: Processes for use of interleukin-1 as an anti-arthritic agent are disclosed, comprising administration of an effective quantity of interleukin-1 (IL-1) in association with a pharmaceutical carrier, to an animal, including man.
    Type: Grant
    Filed: October 29, 1986
    Date of Patent: March 28, 1989
    Assignee: Immunex Corporation
    Inventor: Cindy A. Jacobs